Literature DB >> 30503694

Neuropeptide Y receptor interactions regulate its mitogenic activity.

Magdalena Czarnecka1, Congyi Lu2, Jennifer Pons1, Induja Maheswaran1, Pawel Ciborowski3, Lihua Zhang4, Amrita Cheema4, Joanna Kitlinska5.   

Abstract

Neuropeptide Y (NPY) is a multifunctional neurotransmitter acting via G protein-coupled receptors - Y1R, Y2R and Y5R. NPY activities, such as its proliferative effects, are mediated by multiple receptors, which have the ability to dimerize. However, the role of this receptor interplay in NPY functions remains unclear. The goal of the current study was to identify NPY receptor interactions, focusing on the ligand-binding fraction, and determine their impact on the mitogenic activity of the peptide. Y1R, Y2R and Y5R expressed in CHO-K1 cells formed homodimers detectable on the cell surface by cross-linking. Moreover, Y1R and Y5R heterodimerized, while no Y2R/Y5R heterodimers were detected. Nevertheless, Y5R failed to block internalization of its cognate receptor in both Y1R/Y5R and Y2R/Y5R transfectants, indicating Y5R transactivation upon stimulation of the co-expressed receptor. These receptor interactions correlated with an augmented mitogenic response to NPY. In Y1R/Y5R and Y2R/Y5R transfectants, the proliferative response started at picomolar NPY concentrations, while nanomolar concentrations were needed to trigger proliferation in cells transfected with single receptors. Thus, our data identify direct and indirect heterotypic NPY receptor interactions as the mechanism amplifying its activity. Understanding these processes is crucial for the design of treatments targeting the NPY system.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptors; Heterodimerization; Homodimerization; Neuropeptide Y; Proliferation

Mesh:

Substances:

Year:  2018        PMID: 30503694      PMCID: PMC6532649          DOI: 10.1016/j.npep.2018.11.008

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  57 in total

1.  Limited signal transduction repertoire of human Y(5) neuropeptide Y receptors expressed in HEC-1B cells.

Authors:  A Bischoff; K Püttmann; A Kötting; C Moser; A Buschauer; M C Michel
Journal:  Peptides       Date:  2001-03       Impact factor: 3.750

Review 2.  Glycosylation of G-protein-coupled receptors for hormones central to normal reproductive functioning: its occurrence and role.

Authors:  M Wheatley; S R Hawtin
Journal:  Hum Reprod Update       Date:  1999 Jul-Aug       Impact factor: 15.610

3.  Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells.

Authors:  Michaela C Dinger; Jurgen E Bader; Andreas D Kobor; Antje K Kretzschmar; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

Review 4.  Regulation of olfactory neurogenesis by amidated neuropeptides.

Authors:  D E Hansel; B A Eipper; G V Ronnett
Journal:  J Neurosci Res       Date:  2001-10-01       Impact factor: 4.164

5.  Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Authors:  M Pfeiffer; T Koch; H Schröder; M Klutzny; S Kirscht; H J Kreienkamp; V Höllt; S Schulz
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

6.  Neuropeptide Y-induced angiogenesis in aging.

Authors:  Joanna Kitlinska; Edward W Lee; Sharareh Movafagh; Jennifer Pons; Zofia Zukowska
Journal:  Peptides       Date:  2002-01       Impact factor: 3.750

7.  Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.

Authors:  Jennifer Pons; Joanna Kitlinska; Hong Ji; Edward W Lee; Zofia Zukowska
Journal:  Can J Physiol Pharmacol       Date:  2003-02       Impact factor: 2.273

Review 8.  Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

Authors:  Zofia Zukowska; Jennifer Pons; Edward W Lee; Lijun Li
Journal:  Can J Physiol Pharmacol       Date:  2003-02       Impact factor: 2.273

9.  Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system.

Authors:  K Migita; A D Loewy; T V Ramabhadran; J E Krause; S M Waters
Journal:  Brain Res       Date:  2001-01-19       Impact factor: 3.252

10.  Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Authors:  Edward W Lee; Mieczyslaw Michalkiewicz; Joanna Kitlinska; Ivana Kalezic; Hanna Switalska; Peter Yoo; Amarin Sangkharat; Hong Ji; Lijun Li; Teresa Michalkiewicz; Milos Ljubisavljevic; Hakan Johansson; Derrick S Grant; Zofia Zukowska
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  3 in total

1.  Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.

Authors:  Congyi Lu; Akanksha Mahajan; Sung-Hyeok Hong; Susana Galli; Shiya Zhu; Jason U Tilan; Nouran Abualsaud; Mina Adnani; Stacey Chung; Nada Elmansy; Jasmine Rodgers; Olga Rodriguez; Christopher Albanese; Hongkun Wang; Maureen Regan; Valerie Zgonc; Jan Blancato; Ewa Krawczyk; G Ian Gallicano; Michael Girgis; Amrita Cheema; Ewa Iżycka-Świeszewska; Luciane R Cavalli; Svetlana D Pack; Joanna Kitlinska
Journal:  Nat Commun       Date:  2022-04-28       Impact factor: 17.694

2.  Inhibition of Y1 Receptor Promotes Osteogenesis in Bone Marrow Stromal Cells via cAMP/PKA/CREB Pathway.

Authors:  Wei Yu; Fan-Cheng Chen; Wen-Ning Xu; Sheng-Long Ding; Peng-Bo Chen; Lei Yang; Sheng-Dan Jiang; Xiao-Yun Pan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-10       Impact factor: 5.555

Review 3.  The Role of NPY in the Regulation of Bone Metabolism.

Authors:  Qing-Chang Chen; Yan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.